Emergency medical services naloxone access: a national systematic legal review.

OBJECTIVES Fatal opioid overdose in the United States is at epidemic levels. Naloxone, an effective opioid antidote, is commonly administered by advanced emergency medical services (EMS) personnel in the prehospital setting. While states are rapidly moving to increase access to naloxone for community bystanders, the EMS system remains the primary source for out-of-hospital naloxone access. Many communities have limited advanced EMS response capability and therefore may not have prehospital access to the medication indicated for opioid overdose reversal. The goal of this research was to determine the authority of different levels of EMS personnel to administer naloxone for the reversal of opioid overdose in the United States, Guam, and Puerto Rico. METHODS The authors systematically reviewed the scope of practice of EMS personnel regarding administration of naloxone for the reversal of opioid overdose. All relevant laws, regulations, and policies from the 50 U. S. states, the District of Columbia, Guam, and Puerto Rico in effect in November 2013 were identified, reviewed, and coded to determine the authority of EMS personnel at four levels (in increasing order of training: emergency medical responders [EMRs], emergency medical technicians [EMTs], intermediate/advanced EMTs, and paramedics) to administer naloxone. Where available, protocols governing route and dose of administration were also identified and analyzed. RESULTS All 53 jurisdictions license or certify EMS personnel at the paramedic level, and all permit paramedics to administer naloxone. Of the 48 jurisdictions with intermediate-level EMS personnel, all but one authorized those personnel to administer naloxone as of November 2013. Twelve jurisdictions explicitly permitted EMTs and two permitted EMRs to administer naloxone. At least five jurisdictions modified law or policy to expand EMT access to naloxone in 2013. There is wide variation between states regarding EMS naloxone dosing protocol and route of administration. CONCLUSIONS Naloxone administration is standard for paramedic and intermediate-level EMS personnel, but most states do not allow basic life support (BLS) personnel to administer this medication. Standards consistent with available medical evidence for naloxone administration, dosing, and route of administration should be implemented at each EMS level of certification.

[1]  Sarz Maxwell,et al.  Prescribing Naloxone to Actively Injecting Heroin Users , 2006, Journal of addictive diseases.

[2]  J. Hahn,et al.  Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. , 2012, American journal of epidemiology.

[3]  D. Jolley,et al.  Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. , 2009, Addiction.

[4]  J. Glanz,et al.  National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. , 2013, Drug and alcohol dependence.

[5]  Helen Ashton,et al.  Intranasal naloxone in suspected opioid overdose , 2006, Emergency Medicine Journal.

[6]  K. Khoshnood,et al.  Expanded access to naloxone: options for critical response to the epidemic of opioid overdose mortality. , 2009, American journal of public health.

[7]  Al Ozonoff,et al.  Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis , 2013, BMJ.

[8]  J. Osterwalder Naloxone--for intoxications with intravenous heroin and heroin mixtures--harmless or hazardous? A prospective clinical study. , 1996, Journal of toxicology. Clinical toxicology.

[9]  S. Davis,et al.  Hospitalizations for poisoning by prescription opioids, sedatives, and tranquilizers. , 2010, American Journal of Preventive Medicine.

[10]  Leonard J. Paulozzi,et al.  Vital Signs: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women — United States, 1999–2010 , 2013, MMWR. Morbidity and mortality weekly report.

[11]  L. Paulozzi,et al.  A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it. , 2011, The Journal of clinical psychiatry.

[12]  P. Moyer,et al.  Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. , 2009, American journal of public health.

[13]  Matthew D. Saybolt,et al.  Intranasal naloxone delivery is an alternative to intravenous naloxone for opioid overdoses. , 2010, The American journal of emergency medicine.

[14]  T. S. Jones,et al.  Community-based opioid overdose prevention programs providing naloxone - United States, 2010. , 2012, MMWR. Morbidity and mortality weekly report.

[15]  P I Dargan,et al.  Naloxone in opioid poisoning: walking the tightrope , 2005, Emergency Medicine Journal.

[16]  T. Rea,et al.  Naloxone Use in a Tiered-Response Emergency Medical Services System , 2006, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[17]  Karin A Mack,et al.  Pharmaceutical overdose deaths, United States, 2010. , 2013, JAMA.

[18]  D. Cone,et al.  Knowledge translation in the emergency medical services: a research agenda for advancing prehospital care. , 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[19]  T. Walker FDA approves hand-held auto-injector for reversal of opioid overdose , 2014 .

[20]  A. Walley,et al.  Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. , 2014, American journal of public health.

[21]  Matthew J Lozier,et al.  Acetyl Fentanyl Overdose Fatalities — Rhode Island, March–May 2013 , 2013, MMWR. Morbidity and mortality weekly report.

[22]  Alexander C Wagenaar,et al.  Making the Case for Laws That Improve Health: a Framework for Public Health Law Research , 2022 .

[23]  L. Nelson,et al.  Naloxone hazards overstated. , 1997, Journal of toxicology. Clinical toxicology.

[24]  J. Chamberlain,et al.  A comprehensive review of naloxone for the emergency physician. , 1994, The American journal of emergency medicine.

[25]  S. Burris,et al.  Changing Law from Barrier to Facilitator of Opioid Overdose Prevention , 2013, The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics.

[26]  E. Barton,et al.  I NTRANASAL A DMINISTRATION OF N ALOXONE BY P ARAMEDICS , 2002, Prehospital emergency care : official journal of the National Association of EMS Physicians and the National Association of State EMS Directors.

[27]  Wayne Wakeland,et al.  An analysis of the root causes for opioid-related overdose deaths in the United States. , 2011, Pain medicine.

[28]  S. Comer,et al.  Polydrug abuse: a review of opioid and benzodiazepine combination use. , 2012, Drug and alcohol dependence.

[29]  T. Wolfe,et al.  Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. , 2005, The Journal of emergency medicine.